Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro

22 Feb 2021

Abstract excerpt

BACKGROUND: Treatment options for Stenotrophomonas maltophilia (S. maltophilia) infections were limited. We assessed the efficacy of ceftazidime (CAZ), ceftazidime-avibactam (CAZ-AVI), aztreonam (ATM), and aztreonam-avibactam (ATM-AVI) against a selection of 76 S. maltophilia out of the 1179 strains isolated from the First Affiliated Hospital of Chongqing Medical University during 2011-2018. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fecal contamination and water quality
Share to Hemophilia Treatment and Research
Share to Infections and bacterial resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33618662
DOI: 10.1186/s12866-021-02108-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitroPMID 33618662Read ↗

Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to AztreonamSemantic proximity Read ↗

In vitro activity of ceftazidime/avibactam, cefiderocol, meropenem/vaborbactam and imipenem/relebactam against clinical strains of the Stenotrophomonas maltophilia complexSemantic proximity Read ↗

Clinical challenges treating Stenotrophomonas maltophilia infections: An updateSemantic proximity Read ↗

Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge.Semantic proximity Read ↗

Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative BacteriaSemantic proximity Read ↗

Comparative genomics analysis of Stenotrophomonas maltophilia strains from a communitySemantic proximity Read ↗

Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infectionsSemantic proximity Read ↗

Characterization of Phenotypic and Genotypic Diversity of Stenotrophomonas maltophilia Strains Isolated From Selected Hospitals in IranSemantic proximity Read ↗

A 20-year Trend of Prevalence and Antimicrobial Susceptibility of Stenotrophomonas Maltophilia in a Single Secondary Care Hospital in KoreaSemantic proximity Read ↗

Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against Pseudomonas aeruginosa and Klebsiella pneumoniae Isolates from United States Medical Centers in 2016-2018.Semantic proximity Read ↗

Resistance to ceftazidime–avibactam and underlying mechanismsSemantic proximity Read ↗

Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.